Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viability of Combined Probiotic Strains in Human Gastrointestinal Tract
jRCTs031200138Completed
- Sponsor
- Biofermin Pharmaceutical
- Start
- Oct 2020
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Trial of New Biofermin S Tablets, New Biofermin S Plus Tablets and Lactasin (3 arms), sponsored by Biofermin Pharmaceutical. Primary endpoint: Time series of fecal viable bacterial counts by study drug. Started Oct 2020; status: completed.
02
Drugs
New Biofermin S TabletsNew Biofermin S Plus TabletsLactasin
Beyond the preview
Go deeper on jRCTs031200138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200138.